title: Late response to donor lymphocyte infusions in patients with chronic myeloid leukemia relapsing after allogeneic stem cell transplantation.
abstract: Donor lymphocyte infusions were given to 13 consecutive chronic myeloid leukemia patients in relapse after allogeneic stem cell transplantation. Of the 13 patients, 11 achieved a molecular remission and 2 a cytogenetic remission. The median time (range) in months to achieve a hematologic, cytogenetic and molecular remission was 2 (1-2), 5 (1-42) and 5 the median response duration is 16 months (range 1-36), and no patient shows evidence of relapse.
authors.forename: Marta
authors.initials: M
authors.lastname: Gómez
authors.forename: Alvaro
authors.initials: A
authors.lastname: Urbano-Ispizua
authors.forename: Francisco
authors.initials: F
authors.lastname: Cervantes
authors.forename: Francesc
authors.initials: F
authors.lastname: Fernández-Avilés
authors.forename: Montserrat
authors.initials: M
authors.lastname: Rovira
authors.forename: Enric
authors.initials: E
authors.lastname: Carreras
mesh_terms: D006801:Humans; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000628:therapy*; D017710:Lymphocyte Transfusion; D012008:Recurrence; D033581:Stem Cell Transplantation; D013997:Time Factors; D014184:Transplantation, Homologous; D016896:Treatment Outcome